Table 1. Chart Information Obtained before and after the Quality Improvement Intervention

Before Intervention	After Intervention (≥2 Months Later)
Documentation of informed consent about medication (ACE-I, ARB, or statin) risks	Documentation of informed consent about medication (ACE-I, ARB, or statin) risks
Active prescription for ACE-I, ARB, or statin medications	Active prescription for ACE-I, ARB, or statin medications
Contraceptive methods (surgical and nonsurgical)	Contraceptive methods (surgical and nonsurgical)
Menopausal status	Documentation of quality improvement intervention in the time since the first abstraction
Diagnosis of hypertension, diabetes, or hypercholesterolemia	Documentation of changes in contraceptive methods, medications (ACE-I, ARB, or statin), or both
Patient demographics, including age, insurance, and marital status
Number of visits and number of providers seen at the clinic during the past 12 months
Prescriber type (eg, faculty provider, resident provider, nurse practitioner)

ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.